Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-12
1998-01-06
Jordan, Charles T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4338
Patent
active
057055190
ABSTRACT:
The present invention provides methods for binding a 5-HT.sub.2B receptor in mammals using a both known and novel compounds. Further, the invention provides a method for treating or preventing 5-HT.sub.2B related conditions. Finally, the invention provides an article of manufacture.
REFERENCES:
patent: 4520024 (1985-05-01), Cohen et al.
patent: 4563461 (1986-01-01), Cohen et al.
patent: 4902691 (1990-02-01), Cohen et al.
patent: 4931447 (1990-06-01), Foreman et al.
patent: 4981859 (1991-01-01), Foreman et al.
patent: 5141944 (1992-08-01), Cohen et al.
D. Hoyer et al., Pharmacological Reviews 1994, vol. 46, pp. 157-179 and 191-203, Feb. 1994.
Forbes, Ian T., et al., J. Med. Chem., 36:1104-1107 (1993).
Leonard, B.E., International Clinical Psychopharmacology, 7:13-21 (1992).
Fludzinski, P., Journal of Medicinal Chemistry, 29:2415-2418 (1986).
Kalkman, H.O., Life Sciences, 54:641-644 (1994).
Wainscott David B., Molecular Pharmacology, 43:419-426 (1993).
Foguet M., et al., NeuroReport, 3:345-348 (1992).
Cohen, Marlene L., et al., The Journal of Pharmacology and Experimental Therapeutics, 233:75-79, 770-774 (1985).
Clineschmidt, Bradley V., et al., The Journal of Pharmacology and Experimental Therapeutics, 235:696-708 (1985).
Cohen, Marlene L., et al., Life Sciences, 38:1-5 (1986).
Talley, N. J., Alimentary Pharmacology and Therapeutics, Jun. 1992, vol. 6, p. 273.
Saxena, P. R., et al., Archives Internationales de Pharmacodynamie et de Therapie, Feb. 1985, vol. 277, p. 2.
Woelfel, R. et al., Naunyn-Schmiedeberg's Archives of Pharmacology, Jan. 1992, vol. 345 p. 129.
Snape, M. F., et al., Pharmacology and Toxicology, Jan. 1994, vol. 74, p. 40.
Born, G. V. R., et al., British Journal of Pharmacology, Jan. 1972, vol. 44, p. 117.
Bjorklund, A., et al., Acta Physiologica Scandinavica Supplementum 429, 1975, p. 29, Jun. 1976.
Lessin, A. W., et al., British Journal of Pharmacology and Chemotherapy, Jan. 1967, vol. 29, p. 70.
Kumbar, M., et al., journal of Pharmaceutical Sciences, Jul. 1976, vol. 65, p. 1014.
Audia James E.
Cohen Marlene
Gidda Jaswant S.
Nelson David L.
Boone David E.
Eli Lilly and Company
Hardee John R.
Jordan Charles T.
Vorndran-Jones MaCharri
LandOfFree
Method for treating 5-HT.sub.2B receptor related conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating 5-HT.sub.2B receptor related conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating 5-HT.sub.2B receptor related conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329464